Key Statistics for BOPH
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (USD) (ttm)
|Est. EPS (USD) (06/2013)
|Est. PEG Ratio
|Market Cap (M USD)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for BOPH
- Net Income (M/USD)
Bohai Pharmaceuticals Group, Inc. produces, manufactures, and distributes traditional Chinese herbal medicines, including capsules and other products, in China. The Company's medicines address common health problems such as rheumatism, rheumatoid arthritis, respiratory diseases, viral infections, gynecological diseases and cardiovascular issues.
More Company Profile & Key Executives for BOPH
|Hongwei QuChairman/President/CEO||Hsiao Chin "Gene"Chief Financial Officer|
|Ning TangVP:Operations||Chunhong JiangSecretary/Treasurer|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries